A smaller series of six cases from this series was presented at the Society for Pediatric Dermatology Annual Meeting, Monterey, California, July 2012. Patient 4 in this series was previously published (Behr G, Liberman L, Compton J et al, CM-AVM syndrome in a neonate: case report and treatment with a novel flow reduction strategy. Vasc Cell 2012;4:19). Although we have included this case in our table and overall analysis, we have not highlighted it in the manuscript, nor have we included any previously published images.
Clinical Spectrum of Capillary Malformation–Arteriovenous Malformation Syndrome Presenting to a Pediatric Dermatology Practice: A Retrospective Study
Article first published online: 21 JUL 2014
© 2014 Wiley Periodicals, Inc.
Volume 32, Issue 1, pages 76–84, January/February 2015
How to Cite
Weitz, N. A., Lauren, C. T., Behr, G. G., Wu, J. K., Kandel, J. J., Meyers, P. M., Sultan, S., Anyane-Yeboa, K., Morel, K. D. and Garzon, M. C. (2015), Clinical Spectrum of Capillary Malformation–Arteriovenous Malformation Syndrome Presenting to a Pediatric Dermatology Practice: A Retrospective Study. Pediatric Dermatology, 32: 76–84. doi: 10.1111/pde.12384
- Issue published online: 21 JAN 2015
- Article first published online: 21 JUL 2014
Capillary malformation–arteriovenous malformation syndrome (CM-AVM) is an autosomal dominant disorder caused by RASA1 mutations. The prevalence and phenotypic spectrum are unknown. Evaluation of patients with multiple CMs is challenging because associated AVMs can be life threatening. The objective of this study was to describe the clinical characteristics of children presenting with features of CM-AVM to an academic pediatric dermatology practice. After institutional review board approval was received, a retrospective chart review was performed of patients presenting between 2009 and 2012 with features of CM-AVM. We report nine cases. Presenting symptoms ranged from extensive vascular stains and cardiac failure to CMs noted incidentally during routine skin examination. All demonstrated multiple CMs, two had Parkes Weber syndrome, and two had multiple infantile hemangiomas. Seven patients had family histories of multiple CMs; three had family histories of large, atypical CMs. Six had personal or family histories of AVMs. Genetic evaluation was recommended for all and was pursued by six families; four RASA1 mutations were identified, including one de novo. Consultations with neurology, cardiology, and orthopedics were recommended. Most patients (89%) have not required treatment to date. CM-AVM is an underrecognized condition with a wide clinical spectrum that often presents in childhood. Further evaluation may be indicated in patients with multiple CMs. This study is limited by its small and retrospective nature.